Citation: L. Heilmann et al., The influence of antiphospholipid antibodies on the pregnancy outcome of patients with recurrent spontaneous abortion, CL APPL T-H, 7(4), 2001, pp. 281-285
Authors:
Riisbro, R
Stephens, RW
Brunner, N
Christensen, IJ
Nielsen, HJ
Heilmann, L
von Tempelhoff, GF
Citation: R. Riisbro et al., Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases, GYNECOL ONC, 82(3), 2001, pp. 523-531
Citation: Gf. Von Tempelhoff et al., Correspondence re: N. C. Denko and A. J. Giaccia, tumor hypoxia, the physiological link between Trousseau's syndrome (carcinoma-induced coagulopathy)and metastasis. Cancer Res., 61 : 795-798, 2001., CANCER RES, 61(20), 2001, pp. 7697-7698
Authors:
von Tempelhoff, GF
Nieman, F
Heilmann, L
Hommel, G
Citation: Gf. Von Tempelhoff et al., Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy, CL HEMORH M, 22(2), 2000, pp. 107-130
Citation: Gf. Von Tempelhoff et L. Heilmann, Antithrombotic therapy in gynecologic surgery and gynecologic oncology, HEMAT ONCOL, 14(5), 2000, pp. 1151
Authors:
von Tempelhoff, GF
Heilmann, L
Spanuth, E
Kunzmann, E
Hommel, G
Citation: Gf. Von Tempelhoff et al., Incidence of the factor V Leiden-mutation, coagulation inhibitor deficiency, and elevated antiphospholipid-antibodies in patients with preeclampsia or HELLP-Syndrome, THROMB RES, 100(4), 2000, pp. 363-365
Authors:
Heilmann, L
Schneider, DM
von Tempelhoff, GF
Kuse, S
Citation: L. Heilmann et al., Antiphospholipid-antibodies and other thrombophilic defects in patients with a history of early onset severe preeclampsia or HELLP-syndrome, GEBURTSH FR, 60(2), 2000, pp. 95-100